Search Results

Press Releases

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

October 15, 2024

·

5 min read

Genetown

Omega Therapeutics To Participate In Two Upcoming Investor Conferences - May 30, 2024

Omega Therapeutics, Inc. today announced that management will participate in fireside chats at two upcoming investor conferences.

May 30, 2024

·

1 min read

Press Releases

Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications

September 18, 2024

·

7 min read

Press Releases

Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research

August 14, 2024

·

6 min read

Business

Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

Omega Therapeutics, Inc. today announced the election of Richard N. Kender to its Board of Directors following its annual meeting of stockholders.

June 24, 2024

·

6 min read

Business

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

Omega Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, announced the appointment of Kaan Certel, Ph.D., as Chief Business Officer.

May 29, 2024

·

6 min read

Press Releases

Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

August 6, 2024

·

10 min read

Genetown

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting

Omega Therapeutics, Inc. medicines, today announced it will present a poster at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting taking place in Baltimore, MD, May 7 – 11, 2024.

April 23, 2024

·

5 min read

Genetown

Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco on Thursday, January 11, 2024, at 9:45 a.m. PT (12:45 p.m. ET).

January 2, 2024

·

1 min read

Drug Development

Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers

Omega Therapeutics, Inc. announced the presentation of new preclinical data demonstrating durable and tunable bidirectional regulation of gene expression in cellular models at the pre-transcriptional level at the American Society of Gene and Cell Therapy 27th Annual Meeting, taking place in Baltimore, Maryland, May 7 – 11.

May 8, 2024

·

6 min read